AZGP1 and coronary artery disorder: The receiver-operating characteristic (ROC) curve analysis showed that serum ZAG could distinguish CAD patients (AUC = 0.706, 95% CI, 0.643–0.770, P < 0.05), NCAD patients (AUC = 0.673, 95% CI, 0.602–0.743, P < 0.05), and NCAD and CAD patients (AUC = 0.692, 95% CI, 0.633–0.750, P < 0.05) from controls.